GENE ONLINE|News &
Opinion
Blog

2025-11-27|

Study Explores Effects of 15:9 Time-Restricted Eating on Cognitive Function and Physical Health in Elderly

by GOAI
Share To

A recent study has examined the impact of a 15:9 time-restricted eating (TRE) regimen on cognitive function and physical health in elderly individuals. Researchers investigated whether this specific dietary pattern, which involves consuming food within a 15-hour window followed by a 9-hour fasting period, could influence cognitive abilities and anthropometric measures in aging populations experiencing cognitive decline.

The study, led by Wang et al., focused on how time-restricted eating might affect key health parameters among older adults. The research analyzed changes in cognitive performance alongside physical metrics such as body weight and other anthropometric factors. The findings contribute to ongoing discussions about dietary interventions and their potential role in addressing age-related health challenges, particularly those linked to mental acuity and overall well-being. Further details regarding the methodology or results were not disclosed in the report.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top